<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02348242</url>
  </required_header>
  <id_info>
    <org_study_id>2014-A01197-40</org_study_id>
    <nct_id>NCT02348242</nct_id>
  </id_info>
  <brief_title>Ocular Surface Disorders in Patients in Intensive Care Units, a Comparative Study of Three Preventive Approaches</brief_title>
  <acronym>OCUREA2</acronym>
  <official_title>Ocular Surface Disorders in Patients in Intensive Care Units, a Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      60% of the patients hospitalized in intensive care and sedated suffer from insufficient
      inferior eyelid occlusion. Thus, they are at risk for corneal damage (estimated risk 20% to
      57%). The prevention of such corneal damage can be done using several techniques (artificial
      tears, eyelid occlusion dressing, aqueous gel). The efficacy of these techniques has never
      been compared in a rigorous study. Therefore it is not yet possible to determine an
      evidence-based strategy to prevent corneal damage in intensive care patients.

      This study aims at assessing the efficacy of primary prevention of corneal lesions in
      intensive care patients, in order to elaborate an evidence-based nursing protocol.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence rate of corneal lesions (grade &gt; 0 in the Mercieca classification)</measure>
    <time_frame>participants will be followed for the duration of stay in intensive care unit, an expected average of 1 week</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Corneal Diseases</condition>
  <arm_group>
    <arm_group_label>Aqueous gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the same patient : one eye receives regular administration of aqueous gel (experimental treatment 1) and the other eye receives regular administration of artificial tears (active comparator)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eyelid occlusion dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the same patient : one eye is closed with an eyelid closure dressing (experimental treatment 2) and the other eye receives regular administration of artificial tears (active comparator)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Aqueous Gel</intervention_name>
    <description>1 drop of Dexpanthenol® 0.2% aqueous gel in the eye every 6 hours</description>
    <arm_group_label>Aqueous gel</arm_group_label>
    <other_name>Dexpanthenol® 0.2%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Eyelid Occlusion Dressing</intervention_name>
    <description>Eyelid occlusion using pro-ophta® eyelid occlusion dressing, dressing to be verified every 6 hours and replaced daily</description>
    <arm_group_label>Eyelid occlusion dressing</arm_group_label>
    <other_name>Pro-Ophta® Dressing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Artificial Tears</intervention_name>
    <description>1 drop of Phylarm® artificial tears in the eye every 6 hours</description>
    <arm_group_label>Aqueous gel</arm_group_label>
    <arm_group_label>Eyelid occlusion dressing</arm_group_label>
    <other_name>Phylarm®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patient

          -  hospitalized in an intensive care unit

          -  tracheal intubation and mechanical ventilation since less than 24 hours, with an
             expected duration of artificial ventilation superior to 72h

        Exclusion Criteria:

          -  Patient currently treated by eyedrops for glaucoma

          -  antecedent of corneal transplant

          -  ocular prosthesis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Michel DEVYS, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation Ophtalomologique Adolphe de Rothschild</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fondation ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <state>Ile-de-France</state>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2015</study_first_submitted>
  <study_first_submitted_qc>January 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2015</study_first_posted>
  <last_update_submitted>February 10, 2017</last_update_submitted>
  <last_update_submitted_qc>February 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intensive care</keyword>
  <keyword>corneal damage</keyword>
  <keyword>prevention</keyword>
  <keyword>nursing protocol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lubricant Eye Drops</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

